{"nctId":"NCT00086047","briefTitle":"Coping Skills Training for Adolescents With Fibromyalgia","startDateStruct":{"date":"2004-07"},"conditions":["Fibromyalgia"],"count":114,"armGroups":[{"label":"Coping Skills","type":"EXPERIMENTAL","interventionNames":["Behavioral: Coping Skills Training"]},{"label":"Education","type":"ACTIVE_COMPARATOR","interventionNames":["Behavioral: Education"]}],"interventions":[{"name":"Coping Skills Training","otherNames":["cognitive-behavioral therapy"]},{"name":"Education","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Diagnosis of JPFS based upon widespread pain for over 3 months, at least 5 tender points, and associated features such as sleep difficulty, fatigue, and abdominal discomfort\n* Average pain intensity greater than 4 on the Visual Analog Scale\n* Functional disability score greater than 7\n* Stable medications for 8 weeks prior to study entry\n\nExclusion Criteria:\n\n* Other chronic rheumatic diseases, such as juvenile rheumatoid arthritis or lupus\n* Significant developmental delay or impairments, such as autism, cerebral palsy, or mental retardation\n* Present or lifetime psychiatric diagnosis that meets DSM-IV criteria for panic disorder, bipolar disorder, major depressive disorder, or psychosis\n* Opioid medications are disallowed when used on an ongoing basis for treatment of fibromyalgia pain","healthyVolunteers":false,"sex":"ALL","minimumAge":"11 Years","maximumAge":"18 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in FDI (Functional Disability Inventory) Scores at End of Study","description":"Functional disability score is measured by the Functional Disability Inventory (FDI)which assesses ability to engage in usual physical, social and recreational activities. Scores range from 0=no disability to 60 = extreme disability and and are interpreted as No/Mild disability (0-12); Moderate Disability (13-29) and Severe Disability (30-60)","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21.4","spread":"9.4"},{"groupId":"OG001","value":"19.2","spread":"8.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.4","spread":"8.9"},{"groupId":"OG001","value":"17.0","spread":"10.5"}]}]}]},{"type":"SECONDARY","title":"Pain Intensity","description":null,"paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Depressive Symptoms","description":null,"paramType":null,"dispersionType":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":57},"commonTop":[]}}}